Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (26)

« Back to Publications

Diagnostic accuracy evaluation of a point-of-care antigen test for SARS-CoV-2 and influenza in UK primary care (RAPTOR-C19)

Fanshawe TR. et al, (2025), Plos One, 20

Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysis

Jackson A. et al, (2024), Lancet Oncology, 25, 1476 - 1486

A retrospective analysis of the validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries

Jackson A. et al, (2024), The Lancet Oncology

Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19)

Fanshawe TR. et al, (2024), Clinical Microbiology and Infection, 30, 380 - 386

Using microbiological data to improve the use of antibiotics for respiratory tract infections: A protocol for an individual patient data meta-analysis

Boateng I. et al, (2023), PLoS ONE, 18

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial

Kelly E. et al, (2023), Journal of Infection, 87, 230 - 241

Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19)

Nicholson BD. et al, (2023), PLoS ONE, 18

Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study

Nicholson BD. et al, (2023), Lancet Oncology, 24, 733 - 743

The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme)

Wang K. et al, (2023), Programme Grants for Applied Research, 11, vii - 57

Large-scale observational prospective cohort study of a multi-cancer early detection (MCED) test in symptomatic patients referred for cancer investigation

Nicholson BD. et al, (2023), JOURNAL OF CLINICAL ONCOLOGY, 41

Large-scale observational prospective cohort study of a multi-cancer early detection (MCED) test in symptomatic patients referred for cancer investigation

Nicholson BD. et al, (2023), JOURNAL OF CLINICAL ONCOLOGY, 41, 1501 - 1501

Quality of life, healthcare use and costs in at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: Within-trial descriptive economic analyses of the ARCHIE randomised controlled trial

Rombach I. et al, (2022), BMJ Open, 12

Urine collection devices to reduce contamination in urine samples for diagnosis of uncomplicated UTI: A single-blind randomised controlled trial in primary care

Hayward G. et al, (2022), British Journal of General Practice, 72, 1 - 9

The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): A double-blind randomised placebo-controlled trial

Wang K. et al, (2021), European Respiratory Journal, 58

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Yu LM. et al, (2021), Lancet, 398, 843 - 855

Load More